Xinbin Chen
Impact in
- Oncology top 0.5%
- Cancer-related Molecular Pathways
- Cancer Research top 2%
- MicroRNA in disease regulation
Papers in
- Oncology 110
- Cancer-related Molecular Pathways 106
-
- RNA Research and Splicing 16
- Ubiquitin and proteasome pathways 7
- DNA Repair Mechanisms 5
- Histone Deacetylase Inhibitors Research 4
- Co-authors
- Yingjuan Qian (17 shared papers)Jin Zhang (55 shared papers)Gang Liu (14 shared papers)Yong-Sam Jung (21 shared papers)Jianhui Zhu (11 shared papers)Carol L. Prives (4 shared papers)Jieyuan Jiang (7 shared papers)Ariane Scoumanne (8 shared papers)
- Journals
- Journal of Biological Chemistry (31 papers)Oncogene (15 papers)Molecular and Cellular Biology (14 papers)Cancer Research (11 papers)PLoS ONE (9 papers)
- Partner nations
- United StatesChinaSouth Korea
In The Last Decade
Xinbin Chen
169 papers receiving 9.7k citations
Peers
Comparison fields: 5 of 119
- Oncology 3.7k
- Cancer Research 917
- Molecular Biology 3.6k
- Aging 48
- Developmental Neuroscience 70
Countries citing papers authored by Xinbin Chen
This map shows the geographic impact of Xinbin Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xinbin Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xinbin Chen more than expected).
Fields of papers citing papers by Xinbin Chen
This network shows the impact of papers produced by Xinbin Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xinbin Chen. The network helps show where Xinbin Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Xinbin Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 172 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1998 | 665 | |
| 2 | 2010 | 357 | |
| 3 | The potential tumor suppressor p73 differentially regulates cellular p53 target genes. | 1998 | 283 |
| 4 | 2004 | 264 | |
| 5 | 2001 | 248 | |
| 6 | 2006 | 239 | |
| 7 | 2003 | 233 | |
| 8 | 2002 | 231 | |
| 9 | 2004 | 222 | |
| 10 | 2002 | 179 | |
| 11 | 2011 | 167 | |
| 12 | 2019 | 152 | |
| 13 | 2012 | 151 | |
| 14 | 2015 | 149 | |
| 15 | 1997 | 148 | |
| 16 | 2006 | 148 | |
| 17 | 2000 | 146 | |
| 18 | 2019 | 144 | |
| 19 | p53, through p21 (WAF1/CIP1), induces cyclin D1 synthesis. | 1995 | 142 |
| 20 | 2012 | 137 |
About Xinbin Chen
Xinbin Chen is a scholar working on Oncology, Molecular Biology, Cancer Research, Pulmonary and Respiratory Medicine and Cell Biology, having authored 172 papers that have together received 9.8k indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (106 papers), RNA Research and Splicing (16 papers), Ubiquitin and proteasome pathways (7 papers), DNA Repair Mechanisms (5 papers), Histone Deacetylase Inhibitors Research (4 papers), Cancer, Lipids, and Metabolism (4 papers), Telomeres, Telomerase, and Senescence (4 papers) and MicroRNA in disease regulation (4 papers). The work is most often cited by research in Oncology (3.7k citations), Cancer Research (917 citations), Molecular Biology (3.6k citations), Aging (48 citations) and Developmental Neuroscience (70 citations). Xinbin Chen has collaborated with scholars based in United States, China and South Korea. Frequent co-authors include Yingjuan Qian, Jin Zhang, Gang Liu, Yong-Sam Jung, Jianhui Zhu, Carol L. Prives, Jieyuan Jiang, Ariane Scoumanne, Wensheng Yan and Yanhong Zhang. Their work appears in journals such as Journal of Biological Chemistry, Oncogene, Molecular and Cellular Biology, Cancer Research and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.